Accuracy of Fractional Flow Reserve Derived from Coronary Angiography
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Accuracy of Fractional Flow Reserve Derived from Coronary Angiography. / Fearon, William F.; Achenbach, Stephan; Engstrom, Thomas; Assali, Abid; Shlofmitz, Richard; Jeremias, Allen; Fournier, Stephane; Kirtane, Ajay J.; Kornowski, Ran; Greenberg, Gabriel; Jubeh, Rami; Kolansky, Daniel M.; McAndrew, Thomas; Dressler, Ovidiu; Maehara, Akiko; Matsumura, Mitsuaki; Leon, Martin B.; De Bruyne, Bernard.
I: Circulation, Bind 139, Nr. 4, 2019, s. 477-484.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Accuracy of Fractional Flow Reserve Derived from Coronary Angiography
AU - Fearon, William F.
AU - Achenbach, Stephan
AU - Engstrom, Thomas
AU - Assali, Abid
AU - Shlofmitz, Richard
AU - Jeremias, Allen
AU - Fournier, Stephane
AU - Kirtane, Ajay J.
AU - Kornowski, Ran
AU - Greenberg, Gabriel
AU - Jubeh, Rami
AU - Kolansky, Daniel M.
AU - McAndrew, Thomas
AU - Dressler, Ovidiu
AU - Maehara, Akiko
AU - Matsumura, Mitsuaki
AU - Leon, Martin B.
AU - De Bruyne, Bernard
PY - 2019
Y1 - 2019
N2 - Measuring fractional flow reserve (FFR) with a pressure wire remains underutilized because of the invasiveness of guide wire placement or the need for a hyperemic stimulus. FFR derived from routine coronary angiography (FFRangio) eliminates both of these requirements and displays FFR values of the entire coronary tree. The FFRangio Accuracy versus Standard FFR (FAST-FFR) study is a prospective, multicenter, international trial with the primary goal of determining the accuracy of FFRangio. Methods: Coronary angiography was performed in a routine fashion in patients with suspected coronary artery disease. FFR was measured in vessels with coronary lesions of varying severity using a coronary pressure wire and hyperemic stimulus. Based on angiograms of the respective arteries acquired in ≥2 different projections, on-site operators blinded to FFR then calculated FFRangio using proprietary software. Coprimary end points were the sensitivity and specificity of the dichotomously scored FFRangio for predicting pressure wire-derived FFR using a cutoff value of 0.80. The study was powered to meet prespecified performance goals for sensitivity and specificity. Results: Ten centers in the United States, Europe, and Israel enrolled a total of 301 subjects and 319 vessels meeting inclusion/exclusion criteria which were included in the final analysis. The mean FFR was 0.81 and 43% of vessels had an FFR≤0.80. The per-vessel sensitivity and specificity were 94% (95% CI, 88% to 97%) and 91% (86% to 95%), respectively, both of which exceeded the prespecified performance goals. The diagnostic accuracy of FFRangio was 92% overall and remained high when only considering FFR values between 0.75 to 0.85 (87%). FFRangio values correlated well with FFR measurements (r=0.80, P<0.001) and the Bland-Altman 95% confidence limits were between -0.14 and 0.12. The device success rate for FFRangio was 99%. Conclusions: FFRangio measured from the coronary angiogram alone has a high sensitivity, specificity, and accuracy compared with pressure wire-derived FFR. FFRangio has the promise to substantially increase physiological coronary lesion assessment in the catheterization laboratory, thereby potentially leading to improved patient outcomes. Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique Identifier: NCT03226262.
AB - Measuring fractional flow reserve (FFR) with a pressure wire remains underutilized because of the invasiveness of guide wire placement or the need for a hyperemic stimulus. FFR derived from routine coronary angiography (FFRangio) eliminates both of these requirements and displays FFR values of the entire coronary tree. The FFRangio Accuracy versus Standard FFR (FAST-FFR) study is a prospective, multicenter, international trial with the primary goal of determining the accuracy of FFRangio. Methods: Coronary angiography was performed in a routine fashion in patients with suspected coronary artery disease. FFR was measured in vessels with coronary lesions of varying severity using a coronary pressure wire and hyperemic stimulus. Based on angiograms of the respective arteries acquired in ≥2 different projections, on-site operators blinded to FFR then calculated FFRangio using proprietary software. Coprimary end points were the sensitivity and specificity of the dichotomously scored FFRangio for predicting pressure wire-derived FFR using a cutoff value of 0.80. The study was powered to meet prespecified performance goals for sensitivity and specificity. Results: Ten centers in the United States, Europe, and Israel enrolled a total of 301 subjects and 319 vessels meeting inclusion/exclusion criteria which were included in the final analysis. The mean FFR was 0.81 and 43% of vessels had an FFR≤0.80. The per-vessel sensitivity and specificity were 94% (95% CI, 88% to 97%) and 91% (86% to 95%), respectively, both of which exceeded the prespecified performance goals. The diagnostic accuracy of FFRangio was 92% overall and remained high when only considering FFR values between 0.75 to 0.85 (87%). FFRangio values correlated well with FFR measurements (r=0.80, P<0.001) and the Bland-Altman 95% confidence limits were between -0.14 and 0.12. The device success rate for FFRangio was 99%. Conclusions: FFRangio measured from the coronary angiogram alone has a high sensitivity, specificity, and accuracy compared with pressure wire-derived FFR. FFRangio has the promise to substantially increase physiological coronary lesion assessment in the catheterization laboratory, thereby potentially leading to improved patient outcomes. Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique Identifier: NCT03226262.
KW - coronary artery disease
KW - coronary circulation
KW - fractional flow reserve
KW - myocardial
U2 - 10.1161/CIRCULATIONAHA.118.037350
DO - 10.1161/CIRCULATIONAHA.118.037350
M3 - Journal article
C2 - 30586699
AN - SCOPUS:85060228285
VL - 139
SP - 477
EP - 484
JO - Circulation
JF - Circulation
SN - 0009-7322
IS - 4
ER -
ID: 241042299